These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7065295

  • 1. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM.
    Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
    [Abstract] [Full Text] [Related]

  • 2. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO, Javaid J, Davis JM, Bylund DB.
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [Abstract] [Full Text] [Related]

  • 3. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.
    Shekim WO, Dekirmenjian H, Chapel JL.
    Am J Psychiatry; 1979 May; 136(5):667-71. PubMed ID: 434244
    [Abstract] [Full Text] [Related]

  • 4. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children.
    Brown GL, Ebert MH, Hunt RD, Rapoport JL.
    Biol Psychiatry; 1981 Aug; 16(8):779-87. PubMed ID: 7197170
    [No Abstract] [Full Text] [Related]

  • 5. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity.
    Shekim WO, Sinclair E, Glaser R, Horwitz E, Javaid J, Bylund DB.
    J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828
    [Abstract] [Full Text] [Related]

  • 6. Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine.
    Shekim WO, Dekirmenjian H, Javaid J, Bylund DB, Davis JM.
    J Pediatr; 1982 May; 100(5):830-4. PubMed ID: 7069551
    [Abstract] [Full Text] [Related]

  • 7. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.
    Shekim WO, Dekirmenjian H, Chapel JL, Javaid J, Davis JM.
    J Pediatr; 1979 Sep; 95(3):389-94. PubMed ID: 469661
    [Abstract] [Full Text] [Related]

  • 8. HVA and MHPG in urine of premature infants.
    Garreau B, Domenech J, Martineau J, Barthelemy C, Lelord G, Muh JP.
    Psychiatry Res; 1981 Dec; 5(3):323-30. PubMed ID: 6948311
    [Abstract] [Full Text] [Related]

  • 9. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO, Dekirmenjian H, Chapel JL.
    Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.
    Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL.
    Psychiatry Res; 1994 Jun; 52(3):305-16. PubMed ID: 7527565
    [Abstract] [Full Text] [Related]

  • 11. Urinary catecholamines and amphetamine excretion in hyperactive and normal boys.
    Rapoport JL, Mikkelsen EJ, Ebert MH, Brown GL, Weise VK, Kopin IJ.
    J Nerv Ment Dis; 1978 Oct; 166(10):731-7. PubMed ID: 702130
    [Abstract] [Full Text] [Related]

  • 12. Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
    Kopin IJ, Bankiewicz K, Harvey-White J.
    Life Sci; 1988 Oct; 43(2):133-41. PubMed ID: 3260652
    [Abstract] [Full Text] [Related]

  • 13. Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
    Lobo RA, Shoupe D, Roy S, Paul W.
    Am J Obstet Gynecol; 1984 Jul 01; 149(5):548-52. PubMed ID: 6742025
    [Abstract] [Full Text] [Related]

  • 14. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
    Zametkin AJ, Hamburger SD.
    Biol Psychiatry; 1988 Feb 15; 23(4):350-6. PubMed ID: 3342265
    [Abstract] [Full Text] [Related]

  • 15. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
    Shen YC, Wang YF.
    Biol Psychiatry; 1984 Jun 15; 19(6):861-70. PubMed ID: 6743722
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment.
    Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D.
    Arch Gen Psychiatry; 1985 Oct 15; 42(10):969-73. PubMed ID: 2412521
    [Abstract] [Full Text] [Related]

  • 17. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ, Karoum F, Linnoila M, Rapoport JL, Brown GL, Chuang LW, Wyatt RJ.
    Arch Gen Psychiatry; 1985 Mar 15; 42(3):251-5. PubMed ID: 2579615
    [Abstract] [Full Text] [Related]

  • 18. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
    Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL.
    Arch Gen Psychiatry; 1989 Mar 15; 46(3):205-12. PubMed ID: 2645848
    [Abstract] [Full Text] [Related]

  • 19. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS.
    Clin Pharmacol Ther; 1990 Jul 15; 48(1):57-66. PubMed ID: 2196146
    [Abstract] [Full Text] [Related]

  • 20. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M, Karoum F, Miller T, Potter WZ.
    Am J Psychiatry; 1983 Aug 15; 140(8):1055-7. PubMed ID: 6191580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.